Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease.
about
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21A temporal study of ultrasound contrast agent-induced changes in capillary density.Preemptive conditioning of the swine heart by H11 kinase/Hsp22 provides cardiac protection through inducible nitric oxide synthase.Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.Contemporary perspective on endogenous myocardial regeneration.Cardiovascular gene delivery: The good road is awaitingCardiovascular gene therapy: current status and therapeutic potential.Angiogenic and antiangiogenic gene therapy.Gene and cell therapy for chronic ischaemic heart disease.Myocardial therapeutic angiogenesis: a review of the state of development and future obstaclesTargets for regulating angiogenesis in the ageing endothelium.Gene therapy for ischemic heart disease.Advances in growth factor delivery for therapeutic angiogenesis.Evaluation of ASPIRE trial: a Phase III pivotal registration trial, using intracoronary administration of Generx (Ad5FGF4) to treat patients with recurrent angina pectoris.Angiogenic growth factors in myocardial infarction: a critical appraisal.Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects.Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.Placental growth factor increases regional myocardial blood flow and contractile function in chronic myocardial ischemia.
P2860
Q28084197-BCE7DD37-9703-417B-B04A-35411CC75452Q30476094-A9BAC141-68E3-460A-9416-CE949D6BFB4BQ34784422-3883B7E6-9577-4258-B44B-61FD1E2D94FDQ35069550-EB9868BB-B6F9-4B26-BE3D-91F637669D21Q35070251-0BDD6A4D-23A3-4A90-852A-F86C33344724Q35774278-C8577BAE-423A-4662-832A-71B81ACBB4A1Q35915765-175E327D-9949-4F7C-86DC-D9A7FD72FBBFQ35995220-20690D00-B487-4E76-8092-0CFFC5F27004Q36288905-FB106A21-D008-4646-805A-3FC745323A9EQ36675432-AB664426-F4D1-44C4-81AD-DDB90088E42CQ36820684-237A16F1-5773-496C-8FC8-F74088FF5477Q37008834-C2A939C0-2B50-4731-B11D-1FC59D1585EAQ37857290-F2B41C31-7691-4565-BAF2-88AE29B91611Q38060077-5A5BC9C0-ADDA-4E22-AF9E-1E2371C1BDA1Q38446100-1C67275E-7671-47AC-BC5B-9DBF6DB33CC3Q39389842-8830A278-6B76-444E-B815-67CACBE2030DQ46024791-D870F391-C9BB-472F-A134-6DF4CEF6F86BQ48197251-6266014A-83A1-41E0-97D1-6A719867E4B4Q51838403-C80B48A9-F367-4094-AA68-F6E198719E9F
P2860
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Angiogenic gene therapy with a ...... nt of coronary artery disease.
@ast
Angiogenic gene therapy with a ...... nt of coronary artery disease.
@en
type
label
Angiogenic gene therapy with a ...... nt of coronary artery disease.
@ast
Angiogenic gene therapy with a ...... nt of coronary artery disease.
@en
prefLabel
Angiogenic gene therapy with a ...... nt of coronary artery disease.
@ast
Angiogenic gene therapy with a ...... nt of coronary artery disease.
@en
P2093
P1476
Angiogenic gene therapy with a ...... nt of coronary artery disease.
@en
P2093
Cindy Grines
Gabor M Rubanyi
Matthew W Watkins
Neal S Kleiman
Pran Marrott
P304
P356
10.1016/S0002-9149(03)00965-2
P407
P577
2003-11-01T00:00:00Z